Therapeutic prospects for p73 and p63: Rising from the shadow of p53

被引：49
|
作者：
Vilgelm, Anna [1 ,2 ]
El-Rifai, Wael [1 ,3 ,4 ]
Zaika, Alexander [1 ,3 ,4 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA
[2] Russian Acad Sci, Inst Mol Biol, Dept Cell Biol, Moscow, Russia
[3] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37232 USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
DRUG RESISTANCE UPDATES | 2008年 / 11卷 / 4-5期
关键词：
Apoptosis; E2F1; ZEB1; RETRA; iASPP; YAP1; Drug resistance;
D O I：
10.1016/j.drup.2008.08.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The p53 protein family consists of three transcription factors: p53, p63, and p73. These proteins share significant structural and functional similarities and each has unique biological functions as well. Although the role of p53 in cellular stress is extensively studied, many questions remain about p63 and p73. In this review we summarize current data on functional interactions within the p53 family, their regulation and roles in response to genotoxic stress. We also discuss the significance of p73 and p63 for cancer therapy and outline novel approaches in development of therapeutic drugs that specifically target the p53 family. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码：152 / 163
页数：12
相关论文
共 50 条
  • [11] Phylogenetic analysis of the p53 and p63/p73 gene families
    Pintus, S. S.
    Ivanisenko, V. A.
    PROCEEDINGS OF THE FIFTH INTERNATIONAL CONFERENCE ON BIOINFORMATICS OF GENOME REGULATION AND STRUCTURE, VOL 3, 2006, : 207 - +
  • [12] One, two, three -: p53, p63, p73 and chemosensitivity
    Mueller, Martina
    Schleithoff, Elisa Schulze
    Stremmel, Wolfgang
    Melino, Gerry
    Krammer, Peter H.
    Schilling, Tobias
    DRUG RESISTANCE UPDATES, 2006, 9 (06) : 288 - 306
  • [13] p53, p63, p73:: a true family air, at last!
    Douc-Rasy, S
    Bénard, J
    BULLETIN DU CANCER, 2005, 92 (11) : 933 - 934
  • [14] Evolution of functions within the p53/p63/p73 family
    De Laurenzi, V
    Melino, G
    MECHANISMS OF CELL DEATH II, 2000, 926 : 90 - 100
  • [15] One billion years of p53/p63/p73 evolution
    Belyi, Vladimir A.
    Levine, Arnold J.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (42) : 17609 - 17610
  • [16] p53 family update: p73 and p63 develop their own identities
    Irwin, MS
    Kaelin, WG
    CELL GROWTH & DIFFERENTIATION, 2001, 12 (07): : 337 - 349
  • [17] p63 and p73, members of the p53 gene family, transactivate PKCδ
    Ponassi, Raffaella
    Terrinoni, Alessandro
    Chikh, Anissa
    Rufini, Alessandro
    Lena, Anna Maria
    Sayan, Berna S.
    Melino, Gerry
    Candi, Eleonora
    BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1417 - 1422
  • [18] Structural evolution of p53, p63, and p73: Implication for heterotetramer formation
    Joerger, Andreas C.
    Rajagopalan, Sridharan
    Natan, Eviatar
    Veprintsev, Dmitry B.
    Robinson, Carol V.
    Fersht, Alan R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (42) : 17705 - 17710
  • [19] Contribution of p53, p63, and p73 to the developmental diseases and cancer Minireview
    Tomkova, K.
    Tomka, M.
    Zajac, V.
    NEOPLASMA, 2008, 55 (03) : 177 - 181
  • [20] P53, p63 and p73 - solos, alliances and feuds among family members
    Moll, UM
    Erster, S
    Zaika, A
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1552 (02): : 47 - 59
12345